This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Organ transplantation is a life-saving treatment for many people with organ failure, but it is not without its risks. Transplant patients can experience a variety of complications, ranging from mild to life-threatening. The most common complications of organ transplantation are infection, organ rejection, and graft-versus-host disease. Infection is a major risk of organ transplantation, as the immune system is suppressed in order to prevent organ rejection. This suppression can leave transplant patients vulnerable to a variety of infections, including bacterial and viral infections. It is important for transplant patients to follow their doctor’s instructions for taking antibiotics and other medications to minimize their risk of infection. Organ rejection is one of the most common complications of organ transplantation. The body’s immune system may recognize the transplanted organ as a foreign object and attack it, leading to organ rejection. Doctors monitor their patients closely for signs of organ rejection, and if it is detected, they may be able to treat it with immunosuppressant drugs. Graft-versus-host disease is another major complication of organ transplantation. This condition occurs when the transplanted organ’s cells attack the patient’s own cells, leading to inflammation, organ damage, and other serious health problems. Treatments for graft-versus-host disease involve immune-suppressing medications and supportive care. Other potential complications of organ transplantation include bleeding, blood clots, and organ damage due to complications from surgery. Transplant patients should be closely monitored by their doctor for any signs of potential complications. They should also follow their doctor’s instructions for taking medication and following a healthy lifestyle to minimize the risk of complications.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States